Skip to content

Evaluation of Effectivity of Mustadi Yapan Bast and Baladi Yapan Basti in the Management of very low sperm count-A comparative Study

A Comparative Evaluation of Efficacy of Mustadi Yapan Bast and Baladi Yapan Basti in the Management of Oligozoospermia

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/11/029046
Enrollment
30
Registered
2020-11-11
Start date
Unknown
Completion date
Unknown
Last updated
2024-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N461- Oligospermia

Interventions

Intervention1: Mustadi Yapan and Baladi Yapan Basti: Basti awill be given in the dose of960 ml, Frequency-Once in a day for 21day Route of administration-Anal Duration of therapy 21 Days Control Inter

Sponsors

DR ABHIJIT MURLIDHARRAO AHIRE
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Age group between 25 years to 50 years 2. Sperm count 3. Patients presenting with PratyatmakaLakshana (Cardinal Symptoms) of KshinaShukra, with semen samples suggestive of Oligozoospermia, will be selected.

Exclusion criteria

Exclusion criteria: 1. Age below 25 or above 50 years 2. Sperm count > 20 million/ml 3. Patients with azoospermia and aspermia 4. Genetic Defects like Klinefelter’s syndrome 5. Patients with disease like varicocele, assessory sex gland infection, sexually transmitted diseases, systemic diseases like Diabetes mellitus (DM) etc. will be excluded from the study.

Design outcomes

Primary

MeasureTime frame
Mustadi YapanBasti more effective in the management of OligozoospermiaTimepoint: 4 week

Secondary

MeasureTime frame
To Study the efficacy of MustadiYapanbasti on sperm count sperm motility, semen volume .Semen PH,Abnormal sperm count. To observe samyakNiruhaLakshan and its co relation with oligozoospermia Timepoint: 4 weeks

Countries

India

Contacts

Public ContactDrShweta Parve

MAHATMAGANDHI AYURVWD COLLEGE ,SAWANGI,WARDHA

abhijitahire@gmail.com7774048512

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026